Zheshang Capital
Overview
Zheshang Capital is a Chinese investment firm and a wholly-owned subsidiary of Zheshang Securities, focusing on equity investments, advanced manufacturing, and strategic industrial development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Qingdao Single-Cell Biotechnology Co., Ltd. | Jan 2026 | Series A Extension | Co-investor |
| Zhejiang Drore Technology Co., Ltd. | Jul 2020 | Series B Extension | Lead |
Key People
Mia Hu
Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Zheshang Capital based?
Zheshang Capital is headquartered in Hangzhou, China.
When was Zheshang Capital founded?
Zheshang Capital was founded in 2012.
How many portfolio companies does Zheshang Capital have?
Zheshang Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Zheshang Capital's portfolio?
Portfolio companies visible on Caplight include Qingdao Single-Cell Biotechnology Co., Ltd., Zhejiang Drore Technology Co., Ltd..
What was Zheshang Capital's most recent investment shown here?
Zheshang Capital's most recent investment in this portfolio sample was in Qingdao Single-Cell Biotechnology Co., Ltd. in 2026.
What sectors does Zheshang Capital focus on?
Zheshang Capital focuses on Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Zheshang Capital focus on?
Zheshang Capital typically invests at the Early stage.
What is Zheshang Capital's AUM?
Zheshang Capital's assets under management are estimated between $1.8B and $1.8B.